BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 26925576)

  • 1. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
    J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
    Ryan KM; Allers KA; McLoughlin DM; Harkin A
    Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.
    Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H
    Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia.
    Chen W; Tian Y; Gou M; Wang L; Tong J; Zhou Y; Feng W; Li Y; Chen S; Liu Y; Wang Z; Pan S; Zhang P; Huang J; Yang X; Li CR; Tian L; Hong LE; Tan Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110926. PubMed ID: 38147973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites.
    Aarsland TI; Leskauskaite I; Midttun Ø; Ulvik A; Ueland PM; Oltedal L; Erchinger VJ; Oedegaard KJ; Haavik J; Kessler U
    Brain Stimul; 2019; 12(5):1135-1142. PubMed ID: 31176607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation.
    Hughes MM; Carballedo A; McLoughlin DM; Amico F; Harkin A; Frodl T; Connor TJ
    Brain Behav Immun; 2012 Aug; 26(6):979-87. PubMed ID: 22683764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral and central kynurenine pathway abnormalities in major depression.
    Paul ER; Schwieler L; Erhardt S; Boda S; Trepci A; Kämpe R; Asratian A; Holm L; Yngve A; Dantzer R; Heilig M; Hamilton JP; Samuelsson M
    Brain Behav Immun; 2022 Mar; 101():136-145. PubMed ID: 34999196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression.
    Young KD; Drevets WC; Dantzer R; Teague TK; Bodurka J; Savitz J
    Brain Behav Immun; 2016 Aug; 56():335-42. PubMed ID: 27091600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
    Laugeray A; Launay JM; Callebert J; Surget A; Belzung C; Barone PR
    Behav Brain Res; 2010 Jun; 210(1):84-91. PubMed ID: 20153778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder.
    Savitz J; Dantzer R; Meier TB; Wurfel BE; Victor TA; McIntosh SA; Ford BN; Morris HM; Bodurka J; Teague TK; Drevets WC
    Psychoneuroendocrinology; 2015 Dec; 62():54-8. PubMed ID: 26232650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
    Wang Y; Fang X; Wang G; Tang W; Liu S; Yang Y; Chen J; Ling Y; Zhou C; Zhang X; Zhang C; Su KP
    Brain Behav Immun; 2023 Oct; 113():1-11. PubMed ID: 37353059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder.
    Savitz J; Drevets WC; Wurfel BE; Ford BN; Bellgowan PS; Victor TA; Bodurka J; Teague TK; Dantzer R
    Brain Behav Immun; 2015 May; 46():55-9. PubMed ID: 25686798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder.
    Liu H; Ding L; Zhang H; Mellor D; Wu H; Zhao D; Wu C; Lin Z; Yuan J; Peng D
    Front Psychiatry; 2018; 9():552. PubMed ID: 30510519
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders.
    Li Y; Wang L; Huang J; Zhang P; Zhou Y; Tong J; Chen W; Gou M; Tian B; Li W; Luo X; Tian L; Hong LE; Li CR; Tan Y
    Front Psychiatry; 2024; 15():1357293. PubMed ID: 38680780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central levels of tryptophan metabolites in subjects with bipolar disorder.
    Trepci A; Sellgren CM; Pålsson E; Brundin L; Khanlarkhani N; Schwieler L; Landén M; Erhardt S
    Eur Neuropsychopharmacol; 2021 Feb; 43():52-62. PubMed ID: 33339712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine and its metabolites in Alzheimer's disease patients.
    Gulaj E; Pawlak K; Bien B; Pawlak D
    Adv Med Sci; 2010; 55(2):204-11. PubMed ID: 20639188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.